LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Lung Cancer Screen 18 Tissue Microarray - LS-SLUCA18

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SLUCA18
Product Name: Lung Cancer Screen 18
Description: Lung adenocarcinoma (grade II)
Format: FFPE
Category: Human Tumor
QA/QC: H&E reviewed; IHC validated with a positive control antibody
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Core Diameter: 1.5 mm
Core Thickness: 5 µm
Cases: 21
Cores: 63
Slides Per Set: 1

LS-SLUCA18 Tissue Microarray Map

Slide Number 1
LABEL
 123456789
ALngLngLngLngLngLngLngLngLng
BLngLngLngLngLngLngLngLngLng
CLngLngLngLngLngLngLngLngLng
DLngLngLngLngLngLngLngLngLng
ELngLngLngLngLngLngLngLngLng
FLngLngLngLngLngLngLngLngLng
GLngLngLngLngLngLngLngLngLng
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Lung (Lng);

LS-SLUCA18 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTumor Grade
1A1HumanF53 yLung (Lng)AdenocarcinomaMalignantGrade III
1A2HumanF53 yLung (Lng)AdenocarcinomaMalignantGrade III
1A3HumanF53 yLung (Lng)AdenocarcinomaMalignantGrade III
1A4HumanM30 yLung (Lng)AdenocarcinomaMalignantGrade III
1A5HumanM30 yLung (Lng)AdenocarcinomaMalignantGrade III
1A6HumanM30 yLung (Lng)AdenocarcinomaMalignantGrade III
1A7HumanM69 yLung (Lng)AdenocarcinomaMalignantGrade III
1A8HumanM69 yLung (Lng)AdenocarcinomaMalignantGrade III
1A9HumanM69 yLung (Lng)AdenocarcinomaMalignantGrade III
1B1HumanF68 yLung (Lng)AdenocarcinomaMalignantGrade III
1B2HumanF68 yLung (Lng)Inflammation, ChronicInflammatory 
1B3HumanF68 yLung (Lng)AdenocarcinomaMalignantGrade III
1B4HumanM67 yLung (Lng)NecrosisDiseased 
1B5HumanM67 yLung (Lng)AdenocarcinomaMalignantGrade III
1B6HumanM67 yLung (Lng)AdenocarcinomaMalignantGrade III
1B7HumanM75 yLung (Lng)AdenocarcinomaMalignantGrade III
1B8HumanM75 yLung (Lng)AdenocarcinomaMalignantGrade III
1B9HumanM75 yLung (Lng)AdenocarcinomaMalignantGrade III
1C1HumanF64 yLung (Lng)AdenocarcinomaMalignantGrade III
1C2HumanF64 yLung (Lng)AdenocarcinomaMalignantGrade III
1C3HumanF64 yLung (Lng)AdenocarcinomaMalignantGrade III
1C4HumanM46 yLung (Lng)AdenocarcinomaMalignantGrade III
1C5HumanM46 yLung (Lng)AdenocarcinomaMalignantGrade III
1C6HumanM46 yLung (Lng)AdenocarcinomaMalignantGrade III
1C7HumanF72 yLung (Lng)AdenocarcinomaMalignantGrade III
1C8HumanF72 yLung (Lng)AdenocarcinomaMalignantGrade III
1C9HumanF72 yLung (Lng)AdenocarcinomaMalignantGrade III
1D1HumanF55 yLung (Lng)AdenocarcinomaMalignantGrade III
1D2HumanF55 yLung (Lng)AdenocarcinomaMalignantGrade III
1D3HumanF55 yLung (Lng)AdenocarcinomaMalignantGrade III
1D4HumanM54 yLung (Lng)AdenocarcinomaMalignantGrade III
1D5HumanM54 yLung (Lng)AdenocarcinomaMalignantGrade III
1D6HumanM54 yLung (Lng)AdenocarcinomaMalignantGrade III
1D7HumanF58 yLung (Lng)AdenocarcinomaMalignantGrade III
1D8HumanF58 yLung (Lng)AdenocarcinomaMalignantGrade III
1D9HumanF58 yLung (Lng)AdenocarcinomaMalignantGrade III
1E1HumanM61 yLung (Lng)AdenocarcinomaMalignantGrade III
1E2HumanM61 yLung (Lng)AdenocarcinomaMalignantGrade III
1E3HumanM61 yLung (Lng)AdenocarcinomaMalignantGrade III
1E4HumanF59 yLung (Lng)AdenocarcinomaMalignantGrade III
1E5HumanF59 yLung (Lng)AdenocarcinomaMalignantGrade III
1E6HumanF59 yLung (Lng)AdenocarcinomaMalignantGrade III
1E7HumanF60 yLung (Lng)AdenocarcinomaMalignantGrade III
1E8HumanF60 yLung (Lng)AdenocarcinomaMalignantGrade III
1E9HumanF60 yLung (Lng)AdenocarcinomaMalignantGrade III
1F1HumanM50 yLung (Lng)AdenocarcinomaMalignantGrade III
1F2HumanM50 yLung (Lng)AdenocarcinomaMalignantGrade III
1F3HumanM50 yLung (Lng)AdenocarcinomaMalignantGrade III
1F4HumanM69 yLung (Lng)AdenocarcinomaMalignantGrade III
1F5HumanM69 yLung (Lng)Inflammation, ChronicInflammatory 
1F6HumanM69 yLung (Lng)AdenocarcinomaMalignantGrade III
1F7HumanF41 yLung (Lng)AdenocarcinomaMalignantGrade III
1F8HumanF41 yLung (Lng)AdenocarcinomaMalignantGrade III
1F9HumanF41 yLung (Lng)AdenocarcinomaMalignantGrade III
1G1HumanM64 yLung (Lng)AdenocarcinomaMalignantGrade II
1G2HumanM64 yLung (Lng)AdenocarcinomaMalignantGrade II
1G3HumanM64 yLung (Lng)AdenocarcinomaMalignantGrade II
1G4HumanF39 yLung (Lng)AdenocarcinomaMalignantGrade III
1G5HumanF39 yLung (Lng)AdenocarcinomaMalignantGrade III
1G6HumanF39 yLung (Lng)AdenocarcinomaMalignantGrade III
1G7HumanM51 yLung (Lng)NormalBenign non-neoplastic 
1G8HumanM51 yLung (Lng)NormalBenign non-neoplastic 
1G9HumanM51 yLung (Lng)NormalBenign non-neoplastic 
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved